JPRN-UMIN000011315已完成2 期
The Feasibility Study of Adjuvant nab-paclitaxel+Carboplatin in Patients with Resected Stage IB-IIIA Non-Small-Cell Lung Cance - The Feasibility Study of Adjuvant nab-paclitaxel+Carboplatin in Patients with Resected Stage IB-IIIA Non-Small-Cell Lung Cance
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy for CBDCA/nab-paclitaxel 2) History of Severe drug allergies 3) Myocardial infarction within 6 months 4) Interstitial pneumonia or pulmonary fibrosis detectable on X ray 5)Severe concurrent disease (Ischemic heart disease requiring treatment,arrhythmia,cardiac infarction within 6months before enrollment,hepatic failure,hemorrhagic peptic ulcer,poorly controlled diabetes) 6) History of active double cancerwithin 5years prior to the study 7) HBV-positive patients 8) Patients who are pregnant,considering pregnancy oractaing 9) Other conditions not suitable forthis study
研究者
相似试验
招募中
不适用
Feasibility study of adjuvant nab-paclitaxel in breast cancerbreast cancerJPRN-UMIN000007725Graduate school of medicine,Chiba University55
已完成
2 期
A study of neoadjuvant nab-paclitaxel followed by FEC for luminal B-like (HER2-negative) and triple-negative breast canceruminal B-like (HER2-negative) or triple-negative operable breast cancerJPRN-UMIN000017675Kyushu Breast Cancer Study Group (KBC-SG)94
已完成
2 期
A feasibility study of Nab-Paclitaxel followed by Anthracycline-based regimen as adjuvant chemotherapy for breast cancer.(SBCCSG-21)Primary breast cancerJPRN-UMIN000006084Saitama Breast Cancer Clinical Study Group(SBCCSG)30
已完成
2 期
Pilot study of low-dose Nab-paclitaxel as adjuvant chemotherapy in patients with breast cancerBreast CancerJPRN-UMIN000012047Kitasato University Kitasato Institute Hospital20
已完成
2 期
Phase II study of neoadjuvant nab-paclitaxel and trastuzumab for ER negative and HER2 positive breast cancerER negative and HER2 positive breast cancerJPRN-UMIN000019616Osaka Medical College18
